J. Inokuchi

发表

Targeting ribosomal S6 kinases/Y‐box binding protein‐1 signaling improves cellular sensitivity to taxane in prostate cancer

T. Uchiumi, M. Shiota, M. Itsumi, 2014, The Prostate.

PMA induces androgen receptor downregulation and cellular apoptosis in prostate cancer cells.

T. Uchiumi, M. Shiota, M. Itsumi, 2014, Journal of molecular endocrinology.

Ramucirumab plus docetaxel versus placebo plus docetaxel in patients with locally advanced or metastatic urothelial carcinoma after platinum-based therapy (RANGE): a randomised, double-blind, phase 3 trial

S. Culine, J. Hainsworth, R. Huddart, 2017, The Lancet.

Apparent diffusion coefficient characteristics of various adrenal tumors.

H. Honda, Y. Takayama, A. Nishie, 2014, Magnetic resonance in medical sciences : MRMS : an official journal of Japan Society of Magnetic Resonance in Medicine.

Potential Role for YB-1 in Castration-Resistant Prostate Cancer and Resistance to Enzalutamide Through the Androgen Receptor V7.

Y. Oda, T. Uchiumi, M. Shiota, 2016, Journal of the National Cancer Institute.

Pathological manifestation of difference in washout pattern of adrenal hyperplasia on dynamic CT

H. Honda, Y. Takayama, A. Nishie, 2014, Journal of medical imaging and radiation oncology.

Secondary bladder cancer after anticancer therapy for prostate cancer: Reduced comorbidity after androgen-deprivation therapy.

H. Honda, M. Shiota, A. Yokomizo, 2015 .

Suppressed Recurrent Bladder Cancer after Androgen Suppression with Androgen Deprivation Therapy or 5&agr;‐Reductase Inhibitor

M. Shiota, A. Yokomizo, A. Takeuchi, 2017, The Journal of urology.

Identification of Activated Protein Kinase Cα (PKCα) in the Urine of Orthotopic Bladder Cancer Xenograft Model as a Potential Biomarker for the Diagnosis of Bladder Cancer

J. Inokuchi, T. Kawano, Jeong-Hun Kang, 2021, International journal of molecular sciences.

Impact of antiandrogen withdrawal syndrome in castration‐resistant prostate cancer patients treated with abiraterone or enzalutamide

M. Shiota, A. Yokomizo, A. Takeuchi, 2020, International journal of urology : official journal of the Japanese Urological Association.

Prognostic and Predictive Factors for Anti-androgen Withdrawal in Castration-resistant Prostate Cancer

M. Shiota, A. Takeuchi, E. Kashiwagi, 2018, AntiCancer Research.

Inhibitionof RSK/YB-1Signaling Enhancesthe Anti-Cancer Effectof Enzalutamidein Prostate Cancer

T. Uchiumi, M. Shiota, M. Itsumi, 2014 .

Inhibition of RSK/YB‐1 signaling enhances the anti‐cancer effect of enzalutamide in prostate cancer

T. Uchiumi, M. Shiota, M. Itsumi, 2014, The Prostate.

Cancer Therapy : Preclinical Inhibition of Protein Kinase C / Twist 1 Signaling Augments Anticancer Effects of Androgen Deprivation and Enzalutamide in Prostate Cancer

T. Uchiumi, M. Shiota, A. Yokomizo, 2014 .

Inhibition of Protein Kinase C/Twist1 Signaling Augments Anticancer Effects of Androgen Deprivation and Enzalutamide in Prostate Cancer

T. Uchiumi, M. Shiota, A. Yokomizo, 2013, Clinical Cancer Research.

Periprostatic adipose tissue as a modulator of prostate cancer aggressiveness.

E. Petricoin, D. Ornstein, N. Narula, 2009, The Journal of urology.

Cancer genomic profiling identified dihydropyrimidine dehydrogenase deficiency in bladder cancer promotes sensitivity to gemcitabine

Y. Oda, T. Uchiumi, D. Kang, 2022, Scientific Reports.

Sex‐based differences in CD103+ dendritic cells promote female‐predominant Th2 cytokine production during allergic asthma

J. Inokuchi, T. Kawano, I. Ohno, 2018, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

Impact of nerve sparing in robot‐assisted radical prostatectomy on the risk of positive surgical margin and biochemical recurrence

M. Shiota, E. Kashiwagi, J. Inokuchi, 2022, International journal of urology : official journal of the Japanese Urological Association.

Validation of user-friendly models predicting extracapsular extension in prostate cancer patients

M. Shiota, E. Kashiwagi, J. Inokuchi, 2022, Asian journal of urology.

Human heterochromatin protein 1 isoform HP1beta enhances androgen receptor activity and is implicated in prostate cancer growth.

K. Kuroiwa, N. Seki, Y. Oda, 2010, Endocrine-related cancer.

Apparent diffusion coefficient: An associative factor for recurrence after nephrectomy in localized renal cell carcinoma

H. Honda, Y. Takayama, A. Nishie, 2016, Journal of magnetic resonance imaging : JMRI.

P300/CBP‐associated factor regulates Y‐box binding protein‐1 expression and promotes cancer cell growth, cancer invasion and drug resistance

Ken Yamamoto, K. Kuroiwa, T. Uchiumi, 2010, Cancer science.

Uptake of 18F-FDG in Adrenal Adenomas Is Associated With Unenhanced CT Value and Constituent Cells.

S. Baba, H. Honda, A. Nishie, 2019, Clinical nuclear medicine.

Equol inhibits prostate cancer growth through degradation of androgen receptor by S‐phase kinase‐associated protein 2

T. Uchiumi, M. Shiota, M. Itsumi, 2016, Cancer science.

A rational risk assessment for intravesical recurrence in primary low-grade Ta bladder cancer: A retrospective analysis of 245 cases.

M. Shiota, A. Yokomizo, A. Takeuchi, 2018, Molecular and clinical oncology.

Relationship between body composition and hormone sensitivity for androgen deprivation therapy in patients with metastatic prostate cancer

M. Shiota, A. Takeuchi, K. Imada, 2019, Prostate international.

Comparison of the diagnostic efficacy and perioperative outcomes of limited versus extended pelvic lymphadenectomy during robot-assisted radical prostatectomy: a multi-institutional retrospective study in Japan

J. Inokuchi, Y. Kawano, M. Eto, 2018, International Journal of Clinical Oncology.

Thickness of Perirenal Fat Predicts the Growth Pattern of Renal Cell Carcinoma

M. Shiota, A. Takeuchi, K. Imada, 2020 .

Thick perirenal fat predicts the growth pattern of renal cell carcinoma.

M. Shiota, A. Takeuchi, K. Imada, 2019, Journal of Clinical Oncology.

Thick perirenal fat predicts the growth pattern of renal cell carcinoma

M. Shiota, A. Takeuchi, K. Imada, 2019, bioRxiv.

Genetic Polymorphism in Sex Hormone-binding Globulin With a Prognosis of Androgen Deprivation Therapy in Metastatic Prostate Cancer Among Japanese Men.

T. Uchiumi, M. Shiota, A. Takeuchi, 2019, Clinical genitourinary cancer.

The impact of complications after initial prostate biopsy on repeat protocol biopsy acceptance rate. Results from the Prostate Cancer Research International: Active Surveillance JAPAN study

H. Kume, T. Matsuda, S. Egawa, 2020, International Journal of Clinical Oncology.

Cancer-specific and net overall survival in older patients with de novo metastatic prostate cancer initially treated with androgen deprivation therapy.

H. Nishiyama, T. Habuchi, M. Shiota, 2022, International journal of urology : official journal of the Japanese Urological Association.

Prognostic significance of risk stratification in CHAARTED and LATITUDE studies among Japanese men with castration-resistant prostate cancer

M. Shiota, A. Yokomizo, E. Kashiwagi, 2022, Prostate international.

Anticancer Effect of Second-line Treatment for Castration-Resistant Prostate Cancer Following First-line Treatment with Androgen Receptor Pathway Inhibitors

M. Shiota, A. Yokomizo, A. Takeuchi, 2021, JMA journal.

Prognostic impact of dose reduction in androgen receptor pathway inhibitors for castration-resistant prostate cancer

M. Shiota, A. Yokomizo, A. Takeuchi, 2021, Prostate international.

Predictive factors of survival outcomes in first‐line therapy for metastatic castration‐resistant prostate cancer

M. Shiota, A. Yokomizo, A. Takeuchi, 2021, International journal of urology : official journal of the Japanese Urological Association.

Prognostic impact of prior local therapy in castration-resistant prostate cancer.

M. Shiota, A. Yokomizo, A. Takeuchi, 2021, Japanese journal of clinical oncology.

Differential Impact of TGFB1 Variation by Metastatic Status in Androgen-Deprivation Therapy for Prostate Cancer

T. Uchiumi, M. Shiota, A. Takeuchi, 2021, Frontiers in Oncology.

The prognosis and the impact of radiotherapy in clinically regional lymph node-positive prostate cancer: Which patients are candidates for local therapy with radiation?

Y. Shioyama, M. Shiota, A. Yokomizo, 2020, Urologic oncology.

The impact of genetic polymorphism on CYP19A1 in androgen-deprivation therapy among Japanese men

T. Uchiumi, M. Shiota, A. Takeuchi, 2019, Cancer Chemotherapy and Pharmacology.

Prognostic significance of antihypertensive agents in men with castration-resistant prostate cancer.

M. Shiota, A. Takeuchi, E. Kashiwagi, 2019, Urologic oncology.

Serum testosterone level as possible predictive marker in androgen receptor axis-targeting agents and taxane chemotherapies for castration-resistant prostate cancer.

M. Shiota, A. Takeuchi, K. Imada, 2019, Urologic oncology.

Cigarette smoking augments androgen receptor activity and promotes resistance to antiandrogen therapy

M. Shiota, A. Takeuchi, K. Imada, 2019, The Prostate.

Prognostic significance of diabetes mellitus and dyslipidemia in men receiving androgen-deprivation therapy for metastatic prostate cancer

M. Shiota, A. Takeuchi, E. Kashiwagi, 2019, Prostate international.

Serum Prognostic Factors of Androgen-deprivation Therapy Among Japanese Men With De Novo Metastatic Prostate Cancer

M. Shiota, A. Takeuchi, K. Imada, 2019, AntiCancer Research.

The Association of Polymorphisms in the Gene Encoding Gonadotropin‐Releasing Hormone with Serum Testosterone Level during Androgen Deprivation Therapy and Prognosis of Metastatic Prostate Cancer

T. Uchiumi, M. Shiota, A. Yokomizo, 2017, The Journal of urology.

Serum testosterone before and during androgen‐deprivation therapy, and prognosis between cigarette smokers and nonsmokers with metastatic prostate cancer

M. Shiota, A. Takeuchi, K. Imada, 2018, Andrologia.

Crosstalk between epithelial-mesenchymal transition and castration resistance mediated by Twist1/AR signaling in prostate cancer.

Y. Oda, T. Uchiumi, M. Shiota, 2015, Endocrine-related cancer.

The oncological outcomes and risk stratification in docetaxel chemotherapy for castration-resistant prostate cancer.

M. Shiota, A. Yokomizo, A. Takeuchi, 2014, Japanese journal of clinical oncology.

Polycomb Group Suppressor of Zeste 12 Links Heterochromatin Protein 1α and Enhancer of Zeste 2*

S. Shirasawa, T. Sasazuki, J. Inokuchi, 2004, Journal of Biological Chemistry.

Psoas muscle volume is correlated with sexual activity and erectile dysfunction among patients with localised prostate cancer

M. Shiota, A. Takeuchi, K. Imada, 2019, Andrologia.

Gene polymorphisms in antioxidant enzymes correlate with the efficacy of androgen-deprivation therapy for prostate cancer with implications of oxidative stress

T. Uchiumi, M. Shiota, M. Itsumi, 2016, Annals of oncology : official journal of the European Society for Medical Oncology.

Testosterone level in seminal vesicle fluid is a better indicator of erectile function than serum testosterone in patients with prostate cancer

M. Shiota, A. Takeuchi, K. Imada, 2022, International journal of urology : official journal of the Japanese Urological Association.

Tip60 promotes prostate cancer cell proliferation by translocation of androgen receptor into the nucleus

T. Uchiumi, M. Shiota, A. Yokomizo, 2010, The Prostate.

Statins reduce the androgen sensitivity and cell proliferation by decreasing the androgen receptor protein in prostate cancer cells

K. Kuroiwa, M. Shiota, A. Yokomizo, 2011, The Prostate.

Causes of diminished renal function in the affected kidney after partial nephrectomy

K. Kuroiwa, A. Yokomizo, J. Inokuchi, 2012, BJU international.

Impact of cold and warm ischemia on postoperative recovery of affected renal function after partial nephrectomy.

K. Kuroiwa, A. Yokomizo, A. Takeuchi, 2011, Journal of endourology.

Diversity in treatment modalities of Stage II/III urothelial cancer in Japan: sub-analysis of the multi-institutional national database of the Japanese Urological Association.

H. Nishiyama, T. Miki, E. Kikuchi, 2016, Japanese journal of clinical oncology.

Renal cancer treatment with recipient lymphocyte infusion enhanced the antitumor effect of nonmyeloablative allogeneic stem cell transplantation.

M. Shiota, M. Itsumi, A. Yokomizo, 2015, Transplant immunology.

Impact of multimodal treatment on prognosis for patients with metastatic upper urinary tract urothelial cancer: Subanalysis of the multi‐institutional nationwide case series study of the Japanese Urological Association

H. Nishiyama, E. Kikuchi, J. Inokuchi, 2016, International journal of urology : official journal of the Japanese Urological Association.

Impact of the objective response to and number of cycles of platinum‐based first‐line chemotherapy for metastatic urothelial carcinoma on overall survival of patients treated with pembrolizumab

H. Nishiyama, O. Ogawa, A. Yokomizo, 2021, International journal of urology : official journal of the Japanese Urological Association.

Sorafenib augments cytotoxic effect of S-1 in vitro and in vivo through TS suppression

K. Kuroiwa, M. Shiota, A. Yokomizo, 2011, Cancer Chemotherapy and Pharmacology.

Reliability, validity, and responsiveness of the Japanese version of the EORTC QLQ-ELD14 in evaluating the health-related quality of life of elderly patients with cancer

Masafumi Nakamura, E. Oki, K. Ohuchida, 2022, Journal of Cancer Research and Clinical Oncology.

Association of increased age with decreased response to intravesical instillation of Bacille Calmette-Guérin in patients with high-risk non-muscle invasive bladder cancer: Retrospective multi-institute results from the Japanese Urological Oncology Research Group JUOG-UC-1901-BCG.

H. Nishiyama, T. Habuchi, J. Inokuchi, 2022, Urology.

Deferred radical prostatectomy in patients who initially elected for active surveillance: a multi-institutional, prospective, observational cohort of the PRIAS-JAPAN study

S. Egawa, H. Sasaki, A. Yokomizo, 2021, International Journal of Clinical Oncology.

M. Tsutsumi, J. Inokuchi, H. Kitamura, 2022, Cancer science.

Psoas Muscle Volume Is a Predictive Marker of Fatigue and Anorexia in Prostate Cancer Patients Treated with Enzalutamide

M. Shiota, A. Takeuchi, E. Kashiwagi, 2022, JMA journal.

Downregulation of phosphodiesterase 4B (PDE4B) activates protein kinase A and contributes to the progression of prostate cancer

T. Uchiumi, M. Shiota, M. Itsumi, 2012, The Prostate.

Activators and Inhibitors of Protein Kinase C (PKC): Their Applications in Clinical Trials

J. Inokuchi, T. Kawano, Jeong-Hun Kang, 2021, Pharmaceutics.

Successful management of cryptococcosis of the bilateral adrenal glands and liver by unilateral adrenalectomy with antifungal agents: a case report

K. Ohnaka, J. Inokuchi, K. Tatsugami, 2011, BMC infectious diseases.

Protein Kinase C (PKC) Isozymes as Diagnostic and Prognostic Biomarkers and Therapeutic Targets for Cancer

J. Inokuchi, T. Kawano, Jeong-Hun Kang, 2022, Cancers.

Initial experience with vibegron for the treatment of neurogenic lower urinary tract storage dysfunction in patients with spinal cord injury

M. Shiota, K. Imada, E. Kashiwagi, 2022, Continence.

Foxo3a Suppression of Urothelial Cancer Invasiveness through Twist1, Y-Box–Binding Protein 1, and E-Cadherin Regulation

K. Kuroiwa, Y. Oda, T. Uchiumi, 2010, Clinical Cancer Research.

Sorafenib with doxorubicin augments cytotoxicity to renal cell cancer through PERK inhibition.

K. Kuroiwa, T. Uchiumi, M. Shiota, 2010, International journal of oncology.

EP2 signaling mediates suppressive effects of celecoxib on androgen receptor expression and cell proliferation in prostate cancer

T. Uchiumi, M. Shiota, A. Yokomizo, 2013, Prostate Cancer and Prostatic Disease.

Prostaglandin receptor EP3 mediates growth inhibitory effect of aspirin through androgen receptor and contributes to castration resistance in prostate cancer cells.

T. Uchiumi, M. Shiota, M. Itsumi, 2013, Endocrine-related cancer.

Dermatitis due to epiregulin deficiency and a critical role of epiregulin in immune-related responses of keratinocyte and macrophage.

M. Fujimoto, S. Shirasawa, T. Sasazuki, 2004, Proceedings of the National Academy of Sciences of the United States of America.

Inositol 1,4,5-trisphosphate (IP3) receptor type1 (IP3R1) modulates the acquisition of cisplatin resistance in bladder cancer cell lines

A. Yokomizo, J. Inokuchi, K. Tatsugami, 2005, Oncogene.

Foxo3a expression and acetylation regulate cancer cell growth and sensitivity to cisplatin

K. Kuroiwa, T. Uchiumi, M. Shiota, 2010, Cancer science.

The impact of single-nucleotide polymorphisms on intravesical recurrence after bacillus Calmette-Guérin therapy for non-muscle invasive bladder cancer in a genome-wide association study.

T. Uchiumi, M. Shiota, A. Takeuchi, 2021, Urologic oncology.

Interstitial pneumonia after regression by olaparib for neuroendocrine prostate cancer with BRCA1 mutation: a case report

Y. Oda, M. Shiota, J. Inokuchi, 2023, International Cancer Conference Journal.

Peroxisome proliferator-activated receptor gamma coactivator-1alpha interacts with the androgen receptor (AR) and promotes prostate cancer cell growth by activating the AR.

K. Kuroiwa, T. Uchiumi, M. Shiota, 2010, Molecular endocrinology.

Polymorphisms in androgen metabolism genes with serum testosterone levels and prognosis in androgen-deprivation therapy.

T. Uchiumi, M. Shiota, A. Takeuchi, 2020, Urologic oncology.

Loss of annexin A1 disrupts normal prostate glandular structure by inducing autocrine IL-6 signaling.

Alice Lau, Darren R Tyson, D. Ornstein, 2009, Carcinogenesis.

Laparoscopic Versus Open Nephroureterectomy in Muscle-Invasive Upper Tract Urothelial Carcinoma: Subanalysis of the Multi-Institutional National Database of the Japanese Urological Association.

H. Nishiyama, E. Kikuchi, J. Inokuchi, 2016, Journal of endourology.

Clinical impact of HSD3B1 polymorphism by metastatic volume and somatic HSD3B1 alterations in advanced prostate cancer

Y. Oda, T. Uchiumi, M. Shiota, 2021, Andrologia.

Novel nomogram to predict biochemical recurrence-free survival after radical prostatectomy

M. Shiota, E. Kashiwagi, J. Inokuchi, 2022, World Journal of Urology.

Perioperative therapies for urological cancers.

H. Nishiyama, Y. Tomita, A. Yokomizo, 2020, Japanese journal of clinical oncology.

Prognostic significance of complete blood count parameters in castration-resistant prostate cancer patients treated with androgen receptor pathway inhibitors.

M. Shiota, A. Takeuchi, E. Kashiwagi, 2020, Urologic oncology.

An oral first‐in‐class small molecule RSK inhibitor suppresses AR variants and tumor growth in prostate cancer

M. Shiota, E. Kashiwagi, J. Inokuchi, 2022, Cancer science.

Mineralocorticoid receptor signaling affects therapeutic effect of enzalutamide

T. Uchiumi, M. Shiota, A. Takeuchi, 2018, The Prostate.

MP24-06 INTERACTION BETWEEN DOCETAXEL RESISTANCE AND CASTRATION RESISTANCE IN PROSTATE CANCER: IMPLICATIONS OF TWIST1, YB-1 AND ANDROGEN RECEPTOR

T. Uchiumi, M. Shiota, M. Itsumi, 2014 .

Interaction between docetaxel resistance and castration resistance in prostate cancer: Implications of twist1, YB‐1, and androgen receptor

T. Uchiumi, M. Shiota, A. Yokomizo, 2013, The Prostate.

Culture requirements of prostatic epithelial cell lines for acinar morphogenesis and lumen formation in vitro: Role of extracellular calcium

D. Ornstein, D. Tyson, J. Inokuchi, 2007, The Prostate.

Secondary bladder cancer after anticancer therapy for prostate cancer: reduced comorbidity after androgen-deprivation therapy

H. Honda, M. Shiota, A. Yokomizo, 2015, Oncotarget.

Collateral resistance to taxanes in enzalutamide‐resistant prostate cancer through aberrant androgen receptor and its variants

T. Uchiumi, M. Shiota, A. Takeuchi, 2018, Cancer science.

Gene amplification of YB‐1 in castration‐resistant prostate cancer in association with aberrant androgen receptor expression

Y. Oda, T. Uchiumi, M. Shiota, 2020, Cancer science.

Independent validation of missense polymorphism in HSD3B1 in Japanese men treated with primary androgen-deprivation therapy for metastatic prostate cancer.

T. Uchiumi, M. Shiota, A. Takeuchi, 2018 .

Antitumor activity of recombinant Bacille Calmette-Guérin secreting interleukin-15-Ag85B fusion protein against bladder cancer.

M. Shiota, A. Yokomizo, A. Takeuchi, 2016, International immunopharmacology.

Castration resistance of prostate cancer cells caused by castration-induced oxidative stress through Twist1 and androgen receptor overexpression

T. Uchiumi, M. Shiota, A. Yokomizo, 2010, Oncogene.

Prognostic Impact of Genetic Polymorphism in Mineralocorticoid Receptor and Comorbidity With Hypertension in Androgen-Deprivation Therapy

T. Uchiumi, M. Shiota, A. Takeuchi, 2018, Front. Oncol..

Profile of pembrolizumab in the treatment of patients with unresectable or metastatic urothelial carcinoma

J. Inokuchi, M. Eto, 2019, Cancer management and research.

Protein kinase C regulates Twist1 expression via NF-κB in prostate cancer.

T. Uchiumi, M. Shiota, A. Yokomizo, 2017, Endocrine-related cancer.

Risk factors for febrile neutropenia in patients receiving docetaxel chemotherapy for castration-resistant prostate cancer

M. Shiota, A. Yokomizo, A. Takeuchi, 2014, Supportive Care in Cancer.

A Novel Mechanism of Nuclear Factor κB Activation through the Binding between Inhibitor of Nuclear Factor-κBα and the Processed NH2-terminal Region of Mig-6

S. Shirasawa, T. Sasazuki, J. Inokuchi, 2002 .

The feature of metabolic syndrome is a risk factor for biochemical recurrence after radical prostatectomy

M. Shiota, A. Yokomizo, A. Takeuchi, 2014, Journal of surgical oncology.

Neoadjuvant androgen-deprivation therapy with radical prostatectomy for prostate cancer in association with age and serum testosterone

M. Shiota, A. Takeuchi, K. Imada, 2017, Prostate international.

Impact of smoking on the age at diagnosis of upper tract urothelial carcinoma: Subanalysis of the Japanese Urological Association multi‐institutional national database

H. Nishiyama, E. Kikuchi, J. Inokuchi, 2015, International journal of urology : official journal of the Japanese Urological Association.

Prognostic factors of recurrent disease in upper urinary tract urothelial cancer after radical nephroureterectomy: Subanalysis of the multi‐institutional national database of the Japanese Urological Association

H. Nishiyama, E. Kikuchi, J. Inokuchi, 2015, International journal of urology : official journal of the Japanese Urological Association.

Human heterochromatin protein 1 isoforms regulate androgen receptor signaling in prostate cancer.

T. Uchiumi, M. Shiota, M. Itsumi, 2013, Journal of molecular endocrinology.

Lactate Dehydrogenase Is a Serum Prognostic Factor in Clinically Regional Lymph Node-positive Prostate Cancer

M. Shiota, A. Yokomizo, A. Takeuchi, 2021, Anticancer Research.

Impact of lymph node dissection on clinical outcomes during nephroureterectomy in patients with clinically node-negative upper urinary tract urothelial cancer: subanalysis of a multi-institutional nationwide case series of the Japanese Urological Association

H. Nishiyama, E. Kikuchi, J. Inokuchi, 2017, Japanese journal of clinical oncology.

Role of lymph node dissection during radical nephroureterectomy for upper urinary tract urothelial cancer: multi-institutional large retrospective study JCOG1110A

K. Kuroiwa, O. Ogawa, J. Inokuchi, 2017, World Journal of Urology.

The oncological outcome and validation of Japan Cancer of the Prostate Risk Assessment score among men treated with primary androgen-deprivation therapy

M. Shiota, A. Yokomizo, A. Takeuchi, 2015, Journal of Cancer Research and Clinical Oncology.

Artificial intelligence for segmentation of bladder tumor cystoscopic images performed by U-Net with dilated convolution.

Y. Oda, J. Inokuchi, K. Morooka, 2022, Journal of endourology.

The prognostic impact of serum testosterone during androgen-deprivation therapy in patients with metastatic prostate cancer and the SRD5A2 polymorphism

M. Shiota, A. Yokomizo, A. Takeuchi, 2016, Prostate Cancer and Prostatic Diseases.

Smoking effect on secondary bladder cancer after external beam radiotherapy for prostate cancer.

H. Honda, M. Shiota, A. Yokomizo, 2016, Japanese journal of clinical oncology.

Validation of models predicting lymph node involvement probability in patients with prostate cancer

M. Shiota, A. Takeuchi, E. Kashiwagi, 2022, International journal of urology : official journal of the Japanese Urological Association.

Co‐introduction of a steroid with docetaxel chemotherapy for metastatic castration‐resistant prostate cancer affects PSA flare

M. Shiota, A. Yokomizo, A. Takeuchi, 2016, BJU international.

The Differential Impact of Body Mass Index and the Feature of Metabolic Syndrome on Oncological Outcomes Following Different Surgical Procedures in Japanese Men with Prostate Cancer

M. Shiota, A. Yokomizo, A. Takeuchi, 2017, Annals of surgical oncology.

Surgical Navigation Improves Renal Parenchyma Volume Preservation in Robot-Assisted Partial Nephrectomy: A Propensity Score-matched Comparative Analysis.

M. Hashizume, J. Inokuchi, K. Tatsugami, 2019, The Journal of urology.

Prognostic Value of Lower Tract Urinary Symptoms in Clinically Regional Lymph Node-positive Prostate Cancer

M. Shiota, A. Yokomizo, A. Takeuchi, 2021, AntiCancer Research.

Non-maintenance intravesical Bacillus Calmette–Guérin induction therapy with eight doses in patients with high- or highest-risk non-muscle invasive bladder cancer: a retrospective non-randomized comparative study

H. Nishiyama, J. Inokuchi, M. Uemura, 2021, BMC cancer.

Pembrolizumab for treating advanced urothelial carcinoma in patients with impaired performance status: Analysis of a Japanese nationwide cohort

H. Nishiyama, O. Ogawa, A. Yokomizo, 2021, Cancer medicine.

SRD5A gene polymorphism in Japanese men predicts prognosis of metastatic prostate cancer with androgen-deprivation therapy.

T. Uchiumi, M. Shiota, M. Itsumi, 2015, European journal of cancer.

Smoking effect on oncological outcome among men with prostate cancer after radical prostatectomy

M. Shiota, A. Yokomizo, A. Takeuchi, 2017, Japanese journal of clinical oncology.

Prognostication in Japanese patients with bacillus Calmette‐Guérin‐unresponsive non‐muscle‐invasive bladder cancer undergoing early radical cystectomy

H. Nishiyama, J. Inokuchi, N. Nishiyama, 2021, International journal of urology : official journal of the Japanese Urological Association.

Prostaglandin receptor EP 3 mediates growth inhibitory effect of aspirin through androgen receptor and contributes to castration resistance in prostate cancer cells

T. Uchiumi, M. Shiota, M. Itsumi, 2013 .

High‐throughput screen identifies 5‐HT receptor as a modulator of AR and a therapeutic target for prostate cancer

T. Uchiumi, M. Shiota, M. Itsumi, 2020, The Prostate.

Annexin A2 positively contributes to the malignant phenotype and secretion of IL‐6 in DU145 prostate cancer cells

D. Skarecky, D. Ornstein, David S. Yee, 2009, International journal of cancer.

Impact of Previous, Simultaneous or Subsequent Bladder Cancer on Prognosis after Radical Nephroureterectomy for Upper Urinary Tract Urothelial Carcinoma.

H. Nishiyama, K. Kuroiwa, O. Ogawa, 2019, The Journal of urology.

Subsequent Upper Urinary Tract Carcinoma Related to Worse Survival in Patients Treated with BCG

T. Habuchi, J. Inokuchi, N. Nishiyama, 2023, Cancers.

Clinical factors affecting perioperative outcomes in robot-assisted radical prostatectomy.

M. Shiota, A. Takeuchi, E. Kashiwagi, 2018, Molecular and clinical oncology.

Clinical advantages of robot‐assisted partial nephrectomy versus laparoscopic partial nephrectomy in terms of global and split renal functions: A propensity score‐matched comparative analysis

M. Shiota, A. Takeuchi, E. Kashiwagi, 2021, International journal of urology : official journal of the Japanese Urological Association.

Significance of the timing of ureteral ligation on prognosis during radical nephroureterectomy for upper urinary tract urothelial cancer

H. Nishiyama, K. Kuroiwa, T. Habuchi, 2020, International journal of urology : official journal of the Japanese Urological Association.

Fusion-targeted biopsy significantly improves prostate cancer detection in biopsy-naïve men.

M. Shiota, E. Kashiwagi, J. Inokuchi, 2023, International journal of urology : official journal of the Japanese Urological Association.

Effect of Smoking on Oncological Outcome among Prostate Cancer Patients after Radical Prostatectomy with Neoadjuvant Hormonal Therapy

M. Shiota, A. Yokomizo, A. Takeuchi, 2020, Cancer investigation.

Comparison of the medical costs between active surveillance and other treatments for early prostate cancer in Japan using data from the PRIAS‐JAPAN study

HIroshi G. Okuno, K. Akakura, H. Kinoshita, 2022, International journal of urology : official journal of the Japanese Urological Association.

Significance of prostate-specific antigen-related factors in incidental prostate cancer treated by holmium laser enucleation of the prostate

M. Shiota, A. Yokomizo, J. Inokuchi, 2014, World Journal of Urology.

Prognostic significance of risk stratification in CHAARTED and LATITUDE studies among Japanese men with de novo metastatic prostate cancer

M. Shiota, J. Inokuchi, K. Tatsugami, 2018, International journal of urology : official journal of the Japanese Urological Association.

Prognostic Significance of Preoperative Urine Cytology in Low-grade Non-muscle-invasive Bladder Cancer.

M. Shiota, A. Yokomizo, A. Takeuchi, 2016, Anticancer research.

MR imaging of focal medullary sponge kidney: case report.

H. Honda, A. Nishie, Y. Asayama, 2012, Magnetic resonance in medical sciences : MRMS : an official journal of Japan Society of Magnetic Resonance in Medicine.

Salvage robot-assisted radical prostatectomy after carbon ion radiotherapy: a case report

Y. Shioyama, Y. Oda, M. Shiota, 2021, International Cancer Conference Journal.

Prognostic Impact of Serum Testosterone and Body Mass Index Before Androgen-deprivation Therapy in Metastatic Prostate Cancer.

M. Shiota, A. Yokomizo, A. Takeuchi, 2015, Anticancer research.

Low Serum Testosterone But Not Obesity Predicts High Gleason Score at Biopsy Diagnosed as Prostate Cancer in Patients with Serum PSA Lower than 20 ng/ml.

M. Shiota, A. Yokomizo, A. Takeuchi, 2015, Anticancer research.

Progression to bone-marrow carcinomatosis and extraosseous legion during treatment with radium-223 for multiple bone metastases

S. Baba, H. Honda, Y. Oda, 2018, International Cancer Conference Journal.

1740P Bladder preservation therapy in combination with atezolizumab and radiation therapy for invasive bladder cancer (BPT-ART): An open-label, single-arm, multicenter, phase II trial

T. Tsuzuki, J. Inokuchi, Y. Kageyama, 2022, Annals of Oncology.

Correlation between extended pelvic lymph node dissection and urinary incontinence at early phase after robot‐assisted radical prostatectomy

Y. Oda, M. Shiota, E. Kashiwagi, 2022, International journal of urology : official journal of the Japanese Urological Association.